BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$2.85
Net Income/Share$-0.04
Operating CF/Share$0.24
Free CF/Share$0.23
Cash/Share$1.01
Book Value/Share$-1.85
Tangible Book/Share$-1.85
Equity/Share$-1.85
Interest Debt/Share$3.67
CapEx/Share$0.01
Dividend/Share$0.00
Valuation
Market Cap$1.40B
Enterprise Value$2.00B
P/E Ratio-158.73P/S Ratio2.33P/OCF Ratio28.05
P/FCF Ratio29.51
P/B Ratio-3.59P/TB Ratio-3.59
EV/Sales3.33EV/EBITDA23.80
Graham Valuation
Graham Number--
Graham Net-Net$-2.62
Profitability
Earnings Yield-0.63%FCF Yield3.39%ROE2.02%ROIC25.74%Return on Tangible Assets-1.97%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF4.71%
CapEx/Revenue0.39%
CapEx/Depreciation1.80
SBC/Revenue10.67%
SG&A/Revenue0.00%
R&D/Revenue29.07%
Liquidity & Solvency
Debt/Equity-1.76Debt/Assets1.53Debt/Market Cap0.49
Net Debt/EBITDA7.14
Current Ratio1.87Interest Coverage0.85xIncome Quality-5.66Efficiency
Days Sales Outstanding56 days
Days Payables Outstanding127 days
Days Inventory119 days
Receivables Turnover6.57x
Payables Turnover2.88x
Inventory Turnover3.06x
Capital Structure
Tangible Assets-$387.89M
Working Capital$165.45M
Invested Capital$184.68M
Intangibles/Assets0.00%